Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.
Drugs. 2019 Feb;79(3):303-313. doi: 10.1007/s40265-019-1056-1.
Drugs. 2019.
PMID: 30689194
Review.
Tolvaptan [Jynarque() (USA); Jinarc() (EU, Canada); Samsca() (Japan)] is a highly selective vasopressin V(2) receptor antagonist approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). ...
Tolvaptan [Jynarque() (USA); Jinarc() (EU, Canada); Samsca() (Japan)] is a highly selective vasopressin V(2) receptor antagonist appr …
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.
Blair HA, Keating GM.
Blair HA, et al.
Drugs. 2015 Oct;75(15):1797-806. doi: 10.1007/s40265-015-0475-x.
Drugs. 2015.
PMID: 26407729
Review.
Tolvaptan (Jinarc()) is a highly selective vasopressin V2 receptor antagonist indicated for use in patients with autosomal dominant polycystic kidney disease (ADPKD). ...
Tolvaptan (Jinarc()) is a highly selective vasopressin V2 receptor antagonist indicated for use in patients with autosomal dominant p …
Item in Clipboard
TOLVAPTAN USE IN SEVERE NEONATAL AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): THE PHARMACEUTICAL CHALLENGE.
Olalekan K, Fox A, Gilbert R.
Olalekan K, et al.
Arch Dis Child. 2016 Sep;101(9):e2. doi: 10.1136/archdischild-2016-311535.61.
Arch Dis Child. 2016.
PMID: 27540244
BACKGROUND: Unlicensed medications are used all the time in the management of diseases in childhood. Tolvaptan (Jinarc) is a vasopressin V2-receptor antagonist licensed for use to slow the progression of cyst development and renal insufficiency of ADPKD in adults with CKD …
BACKGROUND: Unlicensed medications are used all the time in the management of diseases in childhood. Tolvaptan (Jinarc) is a vasopres …
Item in Clipboard
Cite
Cite